Back
Innate Pharma SA Vs. Zai Lab Industry Stock Comparison
Buy
58
IPHA
Innate Pharma SA
Last Price:
$2.23
Seasonality Move:
-9.96%
Buy
52
ZLAB
Zai Lab
Last Price:
$28.79
Seasonality Move:
7.22%
Buy
58
Innate Pharma SA (IPHA)
is a Buy
Is Innate Pharma SA a Buy, Sell or Hold?
-
The current Innate Pharma SA [IPHA] share price is $2.32. The Score for IPHA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
IPHA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $2.32The current trend is moderately bullish and IPHA is experiencing slight selling pressure.
ZLAB Stock Price Chart
IPHA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 62.69 | Buy |
Chaikin Money Flow: | -7694 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.85 - 2.27) | Buy |
Bollinger Bands (100): | (1.78 - 2.2) | Buy |
ZLAB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.8 | Sell |
Relative Strength Index (14 RSI): | 43.41 | Sell |
Chaikin Money Flow: | 28021 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.98 - 32.26) | Sell |
Bollinger Bands (100): | (26.05 - 34.31) | Sell |
IPHA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.31 | Buy |
20-day SMA: | 2.13 | Buy |
50-day SMA: | 2.02 | Buy |
200-day SMA: | 2.01 | Buy |
8-day EMA: | 2.3 | Buy |
20-day EMA: | 2.18 | Buy |
50-day EMA: | 2.06 | Buy |
200-day EMA: | 2.07 | Buy |
ZLAB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.85 | Sell |
20-day SMA: | 30.8 | Sell |
50-day SMA: | 32.99 | Sell |
200-day SMA: | 26.92 | Buy |
8-day EMA: | 29.81 | Sell |
20-day EMA: | 30.66 | Sell |
50-day EMA: | 31.3 | Sell |
200-day EMA: | 28.12 | Buy |
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zai Lab Earnings Growth & ZLAB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.43 per share, an increase this year of $1.30 per share, and an increase next year of $1.97 per share.
Innate Pharma SA Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Zai Lab Technical Analysis
Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |